Valuation Scholar Rock Holding Corporation

Stocks

Market Closed - Nasdaq 23:00:00 14/09/2026 +03			5-day change	1st Jan Change
51.85 ^USD	-6.42%		-6.29%	+17.71%

09-14	Scholar Rock's Early FDA Approval on Spinal Muscular Atrophy Drug Seen as 'Positive Surprise,' UBS Says	MT
09-14	Wedbush Adjusts Price Target on Scholar Rock to $70 From $64, Keeps Outperform Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	872.1	467.6	1,356	4,046	4,493	6,748	-	-
Change	-	-46.39%	190.08%	198.32%	11.06%	50.18%	-	-
Enterprise Value (EV) ¹	709.3	414	1,304	3,918	4,270	6,431	6,343	6,378
Change	-	-41.63%	215.07%	200.38%	8.97%	50.62%	-1.36%	0.55%
P/E	-6.92x	-4x	-9.45x	-17.5x	-13.4x	-17.1x	-21.5x	-37.4x
PBR	5.3x	2.07x	6.96x	11x	20.6x	25.4x	22.7x	25.2x
PEG	-	0.1x	0.8x	-0.7x	-0.4x	10.41x	1.1x	0.9x
Capitalization / Revenue	46.3x	14.1x	-	-	-	955x	45.7x	18.9x
EV / Revenue	37.7x	12.5x	-	-	-	910x	43x	17.9x
EV / EBITDA	-5.57x	-	-	-	-11.1x	-15x	-20.6x	-55.5x
EV / EBIT	-5.46x	-3.08x	-7.62x	-15.5x	-11.1x	-14.8x	-18.1x	-34.2x
EV / FCF	-5.37x	-3.1x	-8.98x	-19.5x	-14.2x	-21.8x	-29.1x	-63.7x
FCF Yield	-18.6%	-32.3%	-11.1%	-5.13%	-7.04%	-4.58%	-3.43%	-1.57%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-3.59	-2.26	-1.99	-2.47	-3.29	-3.236	-2.58	-1.481
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	18.82	33.19	-	-	-	7.069	147.6	357.1
EBITDA ¹	-127.3	-	-	-	-383	-429.4	-307.7	-114.9
EBIT ¹	-129.9	-134.4	-171.3	-252.1	-384.6	-435.9	-350.3	-186.7
Net income ¹	-131.8	-134.5	-165.8	-246.3	-377.9	-423.7	-362.4	-204.5
Net Debt ¹	-162.8	-53.53	-51.84	-127.7	-223.8	-317.2	-404.9	-369.9
Reference price ²	24.84	9.05	18.80	43.22	44.05	55.41	55.41	55.41
Nbr of stocks (in thousands)	35,108	51,663	72,143	93,615	102,007	121,785	-	-
Announcement Date	3/7/22 A	3/7/23 A	3/19/24 A	2/27/25 A	3/3/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SCHOLAR ROCK HOLDING CORPORATION	-17.13x	1109.48x	-14.99x	-.--%	6.75B
WUXI APPTEC CO., LTD.	19.64x	6.93x	13.92x	1.51%	66.93B
ARGENX SE	31.94x	9.24x	44.54x	0.04%	61.97B
INSMED INCORPORATED	-79.21x	15.29x	-73.77x	-.--%	28.26B
WUXI BIOLOGICS (CAYMAN) INC.	28.46x	6.03x	15.64x	-.--%	24.59B
BIONTECH SE	-14.63x	5.3x	-6.66x	-.--%	24.3B
GENMAB A/S	26.45x	4.98x	16.56x	-.--%	19.41B
PHARMAESSENTIA CORPORATION	48.28x	17.79x	36.09x	0.31%	16.77B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1225.47x	35.26x	769.42x	-.--%	14.18B
SUMMIT THERAPEUTICS INC.	-15x	3382.33x	-17.29x	-.--%	14B
Average	125.43x	459.26x	78.35x	0.19%	27.72B
Weighted average by Cap.	71.34x	207.39x	48.07x	0.39%